<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39361297</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0215</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of cancer</Title><ISOAbbreviation>Int J Cancer</ISOAbbreviation></Journal><ArticleTitle>Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.35204</ELocationID><Abstract><AbstractText>Treatment modifications and contact restrictions were common during the COVID-19 pandemic and can be stressors for mental health. There is a lack of studies assessing pandemic-related risk factors for anxiety and depression of cancer patients and survivors systematically in multifactorial models. A total of 2391 participants, mean age 65.5 years, ≤5 years post-diagnosis of either lung, prostate, breast, colorectal cancer, or leukemia/lymphoma, were recruited in 2021 via the Baden-Württemberg Cancer Registry, Germany. Sociodemographic information, pandemic-related treatment modifications, contact restrictions, and anxiety/depression (Hospital Anxiety and Depression Scale, HADS) were assessed via self-administered questionnaire. Clinical information (diagnosis, stage, and treatment information) was obtained from the cancer registry. Overall, 22% of participants reported oncological care modifications due to COVID-19, mostly in follow-up care and rehabilitation. Modifications of active cancer treatment were reported by 5.8%. Among those, 50.5% had subclinical anxiety and 55.4% subclinical depression (vs. 37.4% and 45.4%, respectively, for unchanged active treatment). Age &lt;60 years, female sex, lung cancer, low income, and contact restrictions to peer support groups or physicians were identified as independent risk factors for anxiety. Risk factors for depression were lung cancer (both sexes), leukemia/lymphoma (females), recurrence or palliative treatment, living alone, low income, and contact restrictions to relatives, physicians, or caregivers. The study demonstrates that changes in active cancer treatment and contact restrictions are associated with impaired mental well-being. The psychological consequences of treatment changes and the importance for cancer patients to maintain regular contact with their physicians should be considered in future responses to threats to public health.</AbstractText><CopyrightInformation>© 2024 The Author(s). International Journal of Cancer published by John Wiley &amp; Sons Ltd on behalf of UICC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doege</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7499-5376</Identifier><AffiliationInfo><Affiliation>Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiological Cancer Registry of Baden-Württemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frick</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty of Heidelberg, University of Heidelberg, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckford</LastName><ForeName>Rachel D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch-Gallenkamp</LastName><ForeName>Lena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlander</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Health Economics, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Baden‐Württemberg Cancer Registry</CollectiveName></Author><Author ValidYN="Y"><LastName>Arndt</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unit of Cancer Survivorship, Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiological Cancer Registry of Baden-Württemberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Center for Tumor Diseases (NCT) Heidelberg</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cancer</MedlineTA><NlmUniqueID>0042124</NlmUniqueID><ISSNLinking>0020-7136</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS‐CoV‐2</Keyword><Keyword MajorTopicYN="N">cancer registry</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">social contact</Keyword><Keyword MajorTopicYN="N">treatment modifications</Keyword><Keyword MajorTopicYN="N">well‐being</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Bergbold</LastName><ForeName>Susanne</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hermann</LastName><ForeName>Silke</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuldt</LastName><ForeName>Dagmar</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361297</ArticleId><ArticleId IdType="doi">10.1002/ijc.35204</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Burki TK. Cancer care in the time of COVID‐19. Lancet Oncol. 2020;21:628.</Citation></Reference><Reference><Citation>Bundestag. Gesetz zum Ausgleich COVID‐19 bedingter finanzieller Belastungen der Krankenhäuser und weiterer Gesundheitseinrichtungen (COVID‐19‐Krankenhausentlastungsgesetz). [Act to compensate hospitals and other healthcare facilities for financial burdens caused by COVID‐19] Bundesgesetzblatt Teil I, Nr. 14 vom 27.03.2020: Bundesanzeiger, 2020.</Citation></Reference><Reference><Citation>Alom S, Chiu CM, Jha A, Lai SHD, Yau THL, Harky A. The effects of COVID‐19 on cancer care provision: a systematic review. Cancer Control. 2021;28:1‐29.</Citation></Reference><Reference><Citation>Arndt V, Doege D, Fröhling S, et al. Cancer care in German centers of excellence during the first 2 years of the COVID‐19 pandemic. J Cancer Res Clin Oncol. 2023;149:913‐919.</Citation></Reference><Reference><Citation>Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID‐19 pandemic on cancer care. Nat Cancer. 2020;1:1‐3.</Citation></Reference><Reference><Citation>Garfan S, Alamoodi AH, Zaidan BB, et al. Telehealth utilization during the Covid‐19 pandemic: a systematic review. Comput Biol Med. 2021;138:104878.</Citation></Reference><Reference><Citation>Jazieh AR, Akbulut H, Curigliano G, et al. The impact of COVID‐19 pandemic on cancer care: a global collaborative study. JCO Glob Oncol. 2020;6:1428‐1438.</Citation></Reference><Reference><Citation>Riedl D, Schüßler G. Factors associated with and risk factors for depression in cancer patients—a systematic literature review. Transl Oncol. 2022;16:101328.</Citation></Reference><Reference><Citation>Götze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A. Depression and anxiety in long‐term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer. 2020;28:211‐220.</Citation></Reference><Reference><Citation>Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long‐term cancer survivors compared with spouses and healthy controls: a systematic review and meta‐analysis. Lancet Oncol. 2013;14:721‐732.</Citation></Reference><Reference><Citation>Osmani V, Hörner L, Klug SJ, Tanaka LF. Prevalence and risk of psychological distress, anxiety and depression in adolescent and young adult (AYA) cancer survivors: a systematic review and meta‐analysis. Cancer Med. 2023;12:18354‐18367.</Citation></Reference><Reference><Citation>Berger K, Riedel‐Heller S, Pabst A, Rietschel M, Richter D. Loneliness during the first wave of the SARS‐CoV‐2 pandemic‐results of the German National Cohort (NAKO). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64:1157‐1164.</Citation></Reference><Reference><Citation>Peters A, Rospleszcz S, Greiser KH, Dallavalle M, Berger K. The impact of the COVID‐19 pandemic on self‐reported health. Dtsch Arztebl Int. 2020;117:861‐867.</Citation></Reference><Reference><Citation>Dragano N, Reuter M, Peters A, et al. Increase in mental disorders during the COVID‐19 pandemic—the role of occupational and financial strains. Dtsch Arztebl Int. 2022;119:179‐187.</Citation></Reference><Reference><Citation>Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID‐19) on medical staff and general public—a systematic review and meta‐analysis. Psychiatry Res. 2020;291:113190.</Citation></Reference><Reference><Citation>Bäuerle A, Musche V, Schmidt K, et al. Mental health burden of German cancer patients before and after the outbreak of COVID‐19: predictors of mental health impairment. Int J Environ Res Public Health. 2021;18:2318.</Citation></Reference><Reference><Citation>Ayubi E, Bashirian S, Khazaei S. Depression and anxiety among patients with cancer during COVID‐19 pandemic: a systematic review and meta‐analysis. J Gastrointest Cancer. 2021;52:499‐507.</Citation></Reference><Reference><Citation>Verma R, Kilgour HM, Haase KR. The psychosocial impact of COVID‐19 on older adults with cancer: a rapid review. Curr Oncol. 2022;29:589‐601.</Citation></Reference><Reference><Citation>Bartels M, Gal R, van der Velden JM, Verhoeff JJC, Verlaan JJ, Verkooijen HM. Impact of the COVID‐19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study. Clin Exp Metastasis. 2021;38:209‐217.</Citation></Reference><Reference><Citation>Pichler T, Frank T, Maier S, et al. The views of cancer out‐patients on the impact of the COVID‐19 pandemic. Dtsch Med Wochenschr. 2022;147:41‐49.</Citation></Reference><Reference><Citation>Edge R, Mazariego C, Li Z, et al. Psychosocial impact of COVID‐19 on cancer patients, survivors, and carers in Australia: a real‐time assessment of cancer support services. Support Care Cancer. 2021;29:5463‐5473.</Citation></Reference><Reference><Citation>Yildirim OA, Poyraz K, Erdur E. Depression and anxiety in cancer patients before and during the SARS‐CoV‐2 pandemic: association with treatment delays. Qual Life Res. 2021;30:1903‐1912.</Citation></Reference><Reference><Citation>Eckford RD, Gaisser A, Arndt V, et al. The COVID‐19 pandemic and cancer patients in Germany: impact on treatment, follow‐up care and psychological burden. Front Public Health. 2022;9:788598.</Citation></Reference><Reference><Citation>Wang Y, Duan Z, Ma Z, et al. Epidemiology of mental health problems among patients with cancer during COVID‐19 pandemic. Transl Psychiatry. 2020;10:263.</Citation></Reference><Reference><Citation>Annunziata MA, Muzzatti B, Bidoli E, et al. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care Cancer. 2020;28:3921‐3926.</Citation></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361‐370.</Citation></Reference><Reference><Citation>Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69‐77.</Citation></Reference><Reference><Citation>Wu Y, Levis B, Sun Y, et al. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS‐D) to screen for major depression: systematic review and individual participant data meta‐analysis. BMJ. 2021;373:n972.</Citation></Reference><Reference><Citation>Singer S, Kuhnt S, Götze H, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100:908‐912.</Citation></Reference><Reference><Citation>Statistisches Bundesamt (Destatis). Net Income of Households by Household Type, 2021, 2023.</Citation></Reference><Reference><Citation>Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314:1966‐1967.</Citation></Reference><Reference><Citation>Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta‐analysis. BMJ. 2020;371:m4087.</Citation></Reference><Reference><Citation>Nogueira LM, Schafer EJ, Fan Q, et al. Assessment of changes in cancer treatment during the first year of the COVID‐19 pandemic in the US. JAMA Oncol. 2024;10:109‐114.</Citation></Reference><Reference><Citation>van de Poll‐Franse LV, de Rooij BH, Horevoorts NJE, et al. Perceived care and well‐being of patients with cancer and matched norm participants in the COVID‐19 crisis: results of a survey of participants in the Dutch PROFILES Registry. JAMA Oncol. 2021;7:279‐284.</Citation></Reference><Reference><Citation>COVIDSurg Collaborative. Effect of COVID‐19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021;22:1507‐1517.</Citation></Reference><Reference><Citation>Justenhoven C, Rieger B. The impact of the Corona pandemic on reported data relating to cancer diagnoses, therapy, and follow‐up. Dtsch Arztebl Int. 2022;119:724‐725.</Citation></Reference><Reference><Citation>Onesti CE, Tagliamento M, Curigliano G, et al. Expected medium‐ and long‐term impact of the COVID‐19 outbreak in oncology. JCO Glob Oncol. 2021;7:162‐172.</Citation></Reference><Reference><Citation>Hossain MM, Tasnim S, Sultana A, et al. Epidemiology of mental health problems in COVID‐19: a review. F1000Research. 2020;9:636.</Citation></Reference><Reference><Citation>Santomauro DF, Mantilla Herrera AM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID‐19 pandemic. Lancet. 2021;398:1700‐1712.</Citation></Reference><Reference><Citation>Salari N, Hosseinian‐Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID‐19 pandemic: a systematic review and meta‐analysis. Glob Health. 2020;16:57.</Citation></Reference><Reference><Citation>Swainston J, Chapman B, Grunfeld EA, Derakshan N. COVID‐19 lockdown and its adverse impact on psychological health in breast cancer. Front Psychol. 2020;11:2033.</Citation></Reference><Reference><Citation>Gaisser A, Eckford RD, Arndt V, et al. Nearly two years of the coronavirus pandemic from the perspective of people affected by cancer. Der Onkologe. 2022;28:248‐252.</Citation></Reference><Reference><Citation>Frank T, Pichler T, Maier S, et al. Stressors related to the COVID‐19 pandemic and their association with distress, depressive, and anxiety symptoms in cancer out‐patients. Front Psychol. 2023;14:1‐12.</Citation></Reference><Reference><Citation>Wang Y‐H, Li J‐Q, Shi J‐F, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta‐analysis of cohort studies. Mol Psychiatry. 2020;25:1487‐1499.</Citation></Reference><Reference><Citation>Büssing A, Hübner J, Walter S, Gießler W, Büntzel J. Tumor patients' perceived changes of specific attitudes, perceptions, and behaviors due to the COVID‐19 pandemic and its relation to reduced wellbeing. Front Psych. 2020;11:574314.</Citation></Reference><Reference><Citation>Wolf S, Seiffer B, Zeibig JM, et al. Is physical activity associated with less depression and anxiety during the COVID‐19 pandemic? A rapid systematic review. Sports Med. 2021;51:1771‐1783.</Citation></Reference><Reference><Citation>Goerling U, Faller H, Hornemann B, et al. Information needs in cancer patients across the disease trajectory. A prospective study. Patient Educ Couns. 2020;103:120‐126.</Citation></Reference><Reference><Citation>Nekhlyudov L, Duijts S, Hudson SV, et al. Addressing the needs of cancer survivors during the COVID‐19 pandemic. J Cancer Surviv. 2020;14:601‐606.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>